Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP)
Hypertensive Disorders of Pregnancy (HDP) is an independent risk factors of cardiovascular (CVS) disease. The prevalence of Hypertensive Disorders of Pregnancy (HDP) in Malaysia is approximately 23.3 per 1000 live births Endothelin-1 (ET-1), a potent vasoconstriction, has been identified as a piv...
Main Authors: | , , , |
---|---|
Format: | Conference or Workshop Item |
Language: | English English |
Published: |
2019
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/71528/ http://irep.iium.edu.my/71528/ http://irep.iium.edu.my/71528/12/FAOPS%202019%20FINAL%20EDITED%20poster%20pdf.pdf http://irep.iium.edu.my/71528/23/71528_Periodic%20assessment%20of%20%28ET-1%29.pdf |
id |
iium-71528 |
---|---|
recordtype |
eprints |
spelling |
iium-715282019-04-12T04:03:33Z http://irep.iium.edu.my/71528/ Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) Ismawi, Hidayatul Radziah Abdul Razak, Tariq Jamani, Nurjasmine Aida Mohd Zainudin, Maizura R Medicine (General) RA Public aspects of medicine RG Gynecology and obstetrics RG551 Pregnancy Hypertensive Disorders of Pregnancy (HDP) is an independent risk factors of cardiovascular (CVS) disease. The prevalence of Hypertensive Disorders of Pregnancy (HDP) in Malaysia is approximately 23.3 per 1000 live births Endothelin-1 (ET-1), a potent vasoconstriction, has been identified as a pivotal mediator in HDP. Disturbances in nitric oxide (NO) bioavailability found in endothelial dysfunction may increase susceptibility to cardiovascular disease such as hypertension. HDP is defined as systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg during pregnancy. HDP : gestational hypertension (GH), chronic hypertension (CH), pre-eclampsia (PE), and GH/CH superimposed with PE. (GH is diagnosed at >= 20 weeks and resolves <= 12 weeks postpartum. PE: proteinuria component and CH includes women already previously diagnosed with essential hypertension prior to the pregnancy. 2019-03-29 Conference or Workshop Item NonPeerReviewed application/pdf en http://irep.iium.edu.my/71528/12/FAOPS%202019%20FINAL%20EDITED%20poster%20pdf.pdf application/pdf en http://irep.iium.edu.my/71528/23/71528_Periodic%20assessment%20of%20%28ET-1%29.pdf Ismawi, Hidayatul Radziah and Abdul Razak, Tariq and Jamani, Nurjasmine Aida and Mohd Zainudin, Maizura (2019) Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP). In: 9th Federation of the Asian and Oceania Physiological Societies (FAOPS) Congress 2019, 28th-31st March 2019, Kobe, Japan. (Unpublished) http://www.nips.ac.jp/hsdev/FAOPS_2019/index_org.html |
repository_type |
Digital Repository |
institution_category |
Local University |
institution |
International Islamic University Malaysia |
building |
IIUM Repository |
collection |
Online Access |
language |
English English |
topic |
R Medicine (General) RA Public aspects of medicine RG Gynecology and obstetrics RG551 Pregnancy |
spellingShingle |
R Medicine (General) RA Public aspects of medicine RG Gynecology and obstetrics RG551 Pregnancy Ismawi, Hidayatul Radziah Abdul Razak, Tariq Jamani, Nurjasmine Aida Mohd Zainudin, Maizura Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) |
description |
Hypertensive Disorders of Pregnancy (HDP) is an independent risk factors of cardiovascular (CVS) disease.
The prevalence of Hypertensive Disorders of Pregnancy (HDP) in Malaysia is approximately 23.3 per 1000 live births Endothelin-1 (ET-1), a potent vasoconstriction, has been identified as a pivotal mediator in HDP.
Disturbances in nitric oxide (NO) bioavailability found in endothelial dysfunction may increase susceptibility to cardiovascular disease such as hypertension.
HDP is defined as systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg during pregnancy.
HDP : gestational hypertension (GH), chronic hypertension (CH), pre-eclampsia (PE), and GH/CH superimposed with PE. (GH is diagnosed at >= 20 weeks and resolves <= 12 weeks postpartum. PE: proteinuria component and CH includes women already previously diagnosed with essential hypertension prior to the pregnancy. |
format |
Conference or Workshop Item |
author |
Ismawi, Hidayatul Radziah Abdul Razak, Tariq Jamani, Nurjasmine Aida Mohd Zainudin, Maizura |
author_facet |
Ismawi, Hidayatul Radziah Abdul Razak, Tariq Jamani, Nurjasmine Aida Mohd Zainudin, Maizura |
author_sort |
Ismawi, Hidayatul Radziah |
title |
Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) |
title_short |
Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) |
title_full |
Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) |
title_fullStr |
Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) |
title_full_unstemmed |
Periodic assessment of (ET-1) and Nitric Oxide(NO) in hypertensive disorders of pregnancy (HDP) |
title_sort |
periodic assessment of (et-1) and nitric oxide(no) in hypertensive disorders of pregnancy (hdp) |
publishDate |
2019 |
url |
http://irep.iium.edu.my/71528/ http://irep.iium.edu.my/71528/ http://irep.iium.edu.my/71528/12/FAOPS%202019%20FINAL%20EDITED%20poster%20pdf.pdf http://irep.iium.edu.my/71528/23/71528_Periodic%20assessment%20of%20%28ET-1%29.pdf |
first_indexed |
2023-09-18T21:41:25Z |
last_indexed |
2023-09-18T21:41:25Z |
_version_ |
1777413165716340736 |